What is IXHL's earnings growth forecast for 2026-2026?
(NASDAQ: IXHL) Incannex Healthcare's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 127.7%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 52.79%.
Incannex Healthcare's earnings in 2025 is -$21,743,000.
In 2026, IXHL is forecast to generate -$45,916,725 in earnings, with the lowest earnings forecast at -$45,916,725 and the highest earnings forecast at -$45,916,725.
What is IXHL's revenue growth forecast for 2026-2026?
(NASDAQ: IXHL) Incannex Healthcare's forecast annual revenue growth rate of 614.29% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 2.69%, and it is also forecast to beat the US market's average forecast revenue growth rate of 55.02%.
Incannex Healthcare's revenue in 2025 is $98,000.
In 2026, IXHL is forecast to generate $20,603,659 in revenue, with the lowest revenue forecast at $20,603,659 and the highest revenue forecast at $20,603,659.
What is IXHL's forecast return on assets (ROA) for 2026-2026?
(NASDAQ: IXHL) forecast ROA is -283.49%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 12.18%.
What is IXHL's Earnings Per Share (EPS) forecast for 2026-2026?
(NASDAQ: IXHL) Incannex Healthcare's current Earnings Per Share (EPS) is -$1.21. In 2026, IXHL's EPS is forecast to hit -$1.56 (min: -$1.56, max: -$1.56).
What is IXHL's forecast return on equity (ROE) for 2026-2026?
(NASDAQ: IXHL) forecast ROE is -620.24%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.